Third generation platinum drugs offer several advantages over their predecessors. They are often more effective against cancers that have developed resistance to first and second generation drugs. Their modified structures can lead to increased uptake by cancer cells, reduced side effects, and better patient tolerability. This makes them particularly valuable in personalized cancer therapies.
